OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Challenges in Therapeutic Drug Monitoring: Optimizing Biological Treatments in Patients With Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases
Konstantinos Papamichael, Gabriele Stocco, Ainhoa Ruiz del Agua
Therapeutic Drug Monitoring (2023) Vol. 45, Iss. 5, pp. 579-590
Open Access | Times Cited: 10
Konstantinos Papamichael, Gabriele Stocco, Ainhoa Ruiz del Agua
Therapeutic Drug Monitoring (2023) Vol. 45, Iss. 5, pp. 579-590
Open Access | Times Cited: 10
Showing 10 citing articles:
Photodynamic Therapy for Inflammatory and Cancerous Diseases of the Intestines: Molecular Mechanisms and Prospects for Application
Beiying Deng, Kunpeng Wang, Lilong Zhang, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 15, pp. 4793-4810
Open Access | Times Cited: 11
Beiying Deng, Kunpeng Wang, Lilong Zhang, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 15, pp. 4793-4810
Open Access | Times Cited: 11
Practical Management of Biosimilar Use in Inflammatory Bowel Disease (IBD): A Global Survey and an International Delphi Consensus
Ferdinando D’Amico, Virginia Solitano, Fernando Magro, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 19, pp. 6350-6350
Open Access | Times Cited: 8
Ferdinando D’Amico, Virginia Solitano, Fernando Magro, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 19, pp. 6350-6350
Open Access | Times Cited: 8
Reactive Immunomodulator Addition to Infliximab Monotherapy Restores Clinical Response in Inflammatory Bowel Disease: A Meta-Analysis
Jeffrey A. Lowell, G.V.R.K. Sharma, Vincent Chua, et al.
Digestive Diseases and Sciences (2024)
Closed Access | Times Cited: 2
Jeffrey A. Lowell, G.V.R.K. Sharma, Vincent Chua, et al.
Digestive Diseases and Sciences (2024)
Closed Access | Times Cited: 2
Immunogenicity of Therapeutic Antibodies Used for Inflammatory Bowel Disease: Treatment and Clinical Considerations
Ole Haagen Nielsen, Alexander Hammerhøj, Mark Ainsworth, et al.
Drugs (2024)
Closed Access | Times Cited: 2
Ole Haagen Nielsen, Alexander Hammerhøj, Mark Ainsworth, et al.
Drugs (2024)
Closed Access | Times Cited: 2
De-escalation of Biologic Treatment in Inflammatory Bowel Disease: A Comprehensive Review
Javier P. Gisbert, María Chaparro
Journal of Crohn s and Colitis (2023) Vol. 18, Iss. 4, pp. 642-658
Closed Access | Times Cited: 6
Javier P. Gisbert, María Chaparro
Journal of Crohn s and Colitis (2023) Vol. 18, Iss. 4, pp. 642-658
Closed Access | Times Cited: 6
Practical Management of Biosimilar Use in Inflammatory Bowel Disease (IBD): A Global Survey and an International Delphi Consensus
Ferdinando D’Amico, Virginia Solitano, Fernando Magro, et al.
(2023)
Open Access | Times Cited: 4
Ferdinando D’Amico, Virginia Solitano, Fernando Magro, et al.
(2023)
Open Access | Times Cited: 4
Subcutaneous Infliximab Concentration Thresholds for Mucosal and Transmural Healing in Patients With Crohn's Disease
Sung Noh Hong, Joo Hye Song, Sung Jin Kim, et al.
Alimentary Pharmacology & Therapeutics (2024)
Open Access | Times Cited: 1
Sung Noh Hong, Joo Hye Song, Sung Jin Kim, et al.
Alimentary Pharmacology & Therapeutics (2024)
Open Access | Times Cited: 1
Evaluating the Accuracy and Clinical Utility of AFIAS-10 Point of Care Versus Enzyme-Linked Immunosorbent Assay in Therapeutic Drug Monitoring of Infliximab and Adalimumab
Carles Iniesta Navalón, Manuel Ríos-Saorín, Rebeca Añez-Castaño, et al.
Therapeutic Drug Monitoring (2024)
Closed Access
Carles Iniesta Navalón, Manuel Ríos-Saorín, Rebeca Añez-Castaño, et al.
Therapeutic Drug Monitoring (2024)
Closed Access
Impact of ustekinumab exposure on clinical outcomes during induction in inflammatory bowel disease
Carles Iniesta Navalón, Manuel Ríos-Saorín, Lorena Rentero-Redondo, et al.
Revista Española de Enfermedades Digestivas (2024)
Open Access
Carles Iniesta Navalón, Manuel Ríos-Saorín, Lorena Rentero-Redondo, et al.
Revista Española de Enfermedades Digestivas (2024)
Open Access
Biologics in hidradenitis suppurativa: Progress and new directions
Alexandra Charrow, Karla Santiago-Soltero, Martina L. Porter
Journal of the American Academy of Dermatology (2024) Vol. 91, Iss. 6, pp. S27-S30
Closed Access
Alexandra Charrow, Karla Santiago-Soltero, Martina L. Porter
Journal of the American Academy of Dermatology (2024) Vol. 91, Iss. 6, pp. S27-S30
Closed Access
